Andreas Maetzel - Net Worth and Insider Trading
Andreas Maetzel Net Worth
The estimated net worth of Andreas Maetzel is at least $0 dollars as of 2024-11-13. Andreas Maetzel is the Senior Vice President, Medical of KalVista Pharmaceuticals Inc and owns about 0 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $0. Details can be seen in Andreas Maetzel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andreas Maetzel has not made any transactions after 2021-04-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andreas Maetzel
Andreas Maetzel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andreas Maetzel owns 1 companies in total, including KalVista Pharmaceuticals Inc (KALV) .
Click here to see the complete history of Andreas Maetzel’s form 4 insider trades.
Insider Ownership Summary of Andreas Maetzel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2021-04-29 | Senior Vice President Medical |
Andreas Maetzel Latest Holdings Summary
Andreas Maetzel currently owns a total of 1 stock. Andreas Maetzel owns 0 shares of KalVista Pharmaceuticals Inc (KALV) as of April 29, 2021, with a value of $0.
Latest Holdings of Andreas Maetzel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2021-04-29 | 0 | 10.67 | 0 |
Holding Weightings of Andreas Maetzel
Andreas Maetzel Form 4 Trading Tracker
According to the SEC Form 4 filings, Andreas Maetzel has made a total of 1 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 88,030 shares on April 29, 2021, which brought Andreas Maetzel around $2 Million.
Insider Trading History of Andreas Maetzel
- 1
Andreas Maetzel Trading Performance
Andreas Maetzel Ownership Network
Ownership Network List of Andreas Maetzel
Ownership Network Relation of Andreas Maetzel
Andreas Maetzel Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Andreas Maetzel is the Senior Vice President Medical of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include CFO and Secretary Benjamin L Palleiko , Chief Medical Officer Paul K. Audhya , and Chief Development Officer Christopher Yea .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Andreas Maetzel made no insider transaction in KalVista Pharmaceuticals Inc (KALV). Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 144,760 shares made by Benjamin L Palleiko , and a net sale of 116,267 shares made by Edward P. Feener .
In summary, during the past 3 months, insiders sold 40,693 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 40,693 shares. During the past 18 months, 583,370 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 667,647 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Andreas Maetzel Mailing Address
Above is the net worth, insider trading, and ownership report for Andreas Maetzel. You might contact Andreas Maetzel via mailing address: 1255 Crescent Green Drive, Suite 250, Cary Nc 27518.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
